Scholars@Duke

Combinatorial TGF-β signaling blockade and anti-CTLA-4 antibody immunotherapy in a murine BRAFV600E-PTEN-/- transgenic model of melanoma.

Publication ,  Conference
Hanks, BA; Holtzhausen, A; Evans, K; Heid, M; Blobe, GC
Published in: Journal of Clinical Oncology
May 20, 2014
Published version (DOI) Publisher Link

Duke Scholars

Brent A. Hanks
Author Brent A. Hanks Medicine, Medical Oncology
Gerard Conrad Blobe
Author Gerard Conrad Blobe Medicine, Medical Oncology

Published In

Journal of Clinical Oncology

DOI

10.1200/jco.2014.32.15_suppl.3011

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2014

Volume

32

Issue

15_suppl

Start / End Page

3011 / 3011

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hanks, B. A., Holtzhausen, A., Evans, K., Heid, M., & Blobe, G. C. (2014). Combinatorial TGF-β signaling blockade and anti-CTLA-4 antibody immunotherapy in a murine BRAFV600E-PTEN-/- transgenic model of melanoma. In Journal of Clinical Oncology (Vol. 32, pp. 3011–3011). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2014.32.15_suppl.3011
Hanks, Brent Allen, Alisha Holtzhausen, Kathy Evans, Michelle Heid, and Gerard C. Blobe. “Combinatorial TGF-β signaling blockade and anti-CTLA-4 antibody immunotherapy in a murine BRAFV600E-PTEN-/- transgenic model of melanoma.” In Journal of Clinical Oncology, 32:3011–3011. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.15_suppl.3011.
Hanks BA, Holtzhausen A, Evans K, Heid M, Blobe GC. Combinatorial TGF-β signaling blockade and anti-CTLA-4 antibody immunotherapy in a murine BRAFV600E-PTEN-/- transgenic model of melanoma. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 3011–3011.
Hanks, Brent Allen, et al. “Combinatorial TGF-β signaling blockade and anti-CTLA-4 antibody immunotherapy in a murine BRAFV600E-PTEN-/- transgenic model of melanoma.” Journal of Clinical Oncology, vol. 32, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2014, pp. 3011–3011. Crossref, doi:10.1200/jco.2014.32.15_suppl.3011.
Hanks BA, Holtzhausen A, Evans K, Heid M, Blobe GC. Combinatorial TGF-β signaling blockade and anti-CTLA-4 antibody immunotherapy in a murine BRAFV600E-PTEN-/- transgenic model of melanoma. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 3011–3011.

Published In

Journal of Clinical Oncology

DOI

10.1200/jco.2014.32.15_suppl.3011

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2014

Volume

32

Issue

15_suppl

Start / End Page

3011 / 3011

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences